Skip to main content

Table 1 Demographics of patients with idiopathic pulmonary fibrosis in the 2 study groups

From: Prevalence, risk factors, and impact of lung Cancer on outcomes of idiopathic pulmonary fibrosis: a study from the Middle East

Characteristic

All IPF

IPF and LC

IPF only

P

Subjects No. (%)

246 (100)

34 (13.8)

212 (86.2)

0.000

Age,± SD, y

52.4 ± 8.2

56.6 ± 10.0

47.7 ± 10.2

0.002

Gender No. (%)

   

0.107

 Male

171 (69.5)

28(82.3)

143 (67.4)

 

 Female

75 (30.5)

6 (17.7)

69 (32.6)

 

Smoking status

   

0.033

 Current

180 (73.2)

22 (64.6)

158 (74.4)

 

 Past

31 (12.6)

4 (11.8)

27 (12.8)

 

 Never

35 (14.2)

8 (23.6)

27 (12.8)

 

Pack/years

33.4 ± 16.7

37.2 ± 21.7

30.7 ± 13.1

0.016

FVC (% pred)

80.8 ± 2.9

85.9 ± 2.7

77.1 ± 3.8

0.000

FEV1(% pred)

82.3 ± 5.0

87.0 ± 4.8

76.9 ± 5.9

0.010

TLC (% pred)

69.2 ± 10.1

70.1 ± 12.8

67.8 ± 9.3

0.206

DLCO (% pred)

60.2 ± 8.3

57.1 ± 10.4

62.6 ± 9.5

0.000

Diagnostic method

   

0.021

 Clinical

218 (88.6)

26 (76.5)

192 (90.6)

 

 Surgical

28 (11.4)

8 (23.5)

20 (9.4)

 

AEIPF

87 (35.3)

18 (53)

69 (32.5)

0.032

  1. Data are presented as mean ± SD, percentage or median (min-max) unless otherwise indicated. % pred, percentage of the predicted value; FVC; forced vital capacity, FEV1; forced expiratory volume in 1 s, TLC; total lung capacity, DLCO; diffusing capacity of the lung for carbon monoxide, AEIPF; acute exacerbations of idiopathic pulmonary fibrosis